tradingkey.logo
tradingkey.logo
Search

Bio Rad Laboratories Inc

BIOb
Add to Watchlist
321.500USD
+25.010+8.44%
Close 06/26, 16:00ETQuotes delayed by 15 min
8.63BMarket Cap
53.32P/E TTM

Bio Rad Laboratories Inc

321.500
+25.010+8.44%
View Detailed Chart
TradingKey 图表
Intraday
1m
30m
1h
D
W
M
D

Today

+8.44%

5 Days

+14.56%

1 Month

+5.70%

6 Months

+5.70%

Year to Date

+5.41%

1 Year

0.00%

Key Figures
--Open
0.000High
3.00Volume
53.32P/E TTM
--P/E Dynamic
--Dividend TTM
0.00%Turnover Ratio
296.490Prev. Close
0.000Low
643.00Turnover
LossP/E Static
1.26P/B
0.00%Div Yield TTM
1.75%ROA
321.12052wk High
0.01Volume Ratio
-1.84BNet Profit
26.83MShares
6.0298EPS TTM
0.98Beta
2.50%ROE
244.54052wk Low
0.00%Amplitude
52.25%Gross Margin
8.63BMarket Cap
-13.39Reward/Risk
0.80%Risk Rate

Key Insights

Bio Rad Laboratories Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 159 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very low.In the medium term, the stock price is expected to remain stable.Despite a good stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Bio Rad Laboratories Inc's Score

Industry at a Glance

Industry Ranking
159 / 204
Overall Ranking
429 / 4571
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Analyst Rating

Based on 0 analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Bio Rad Laboratories Inc Highlights

StrengthsRisks
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Overvalued
The company’s latest PE is 49.17, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 3.75K shares, decreasing 5.83% quarter-over-quarter.

Bio Rad Laboratories Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Bio Rad Laboratories Inc Info

Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Ticker SymbolBIOb
CompanyBio Rad Laboratories Inc
CEOSchwartz (Norman D)
Websitehttps://www.bio-rad.com/

FAQs

What is the current price of Bio Rad Laboratories Inc (BIOb)?

The current price of Bio Rad Laboratories Inc (BIOb) is 321.50.

What is the symbol of Bio Rad Laboratories Inc?

The ticker symbol of Bio Rad Laboratories Inc is BIOb.

What is the 52-week high of Bio Rad Laboratories Inc?

The 52-week high of Bio Rad Laboratories Inc is 321.12.

What is the 52-week low of Bio Rad Laboratories Inc?

The 52-week low of Bio Rad Laboratories Inc is 244.54.

What is the market capitalization of Bio Rad Laboratories Inc?

The market capitalization of Bio Rad Laboratories Inc is 8.03B.

What is the Earnings Per Share (EPS TTM) of Bio Rad Laboratories Inc (BIOb)?

The Earnings Per Share (EPS TTM) of Bio Rad Laboratories Inc (BIOb) is 27.87.
KeyAI